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THE ROLE OF IMPAIRED ANGIOGENESIS ON  
PERIVASCULAR ADIPOSE TISSUE AND MACROVASCULAR FUNCTION 
RAFFI ABRAHAM GHARAKHANIAN 
ABSTRACT 
 
Objective. Only recently has hypoxia within the adipose tissue 
microenvironment been suggested to influence metabolic dysfunction and 
cardiovascular complications. Although its exact function is largely unknown, 
thoracic perivascular adipose tissue (PVAT) has been shown to release factors 
which influence vascular function. The objective of this study is to determine if 
vascular endothelial growth factor-A (VEGF-A) within PVAT plays a role in the 
maintenance of aortic structure and function.  
    Materials/Methods. Mice with adipose-specific deficiency of VEGF were 
previously generated in the lab. Fabp4cre(+).VEGFflox/flox and  
Fabp4cre(-).VEGFflox/flox mice were maintained on chow diet for the entirety of this 
study. PVAT gene expression was measured with real time quantitative PCR. 
Aortic vasomotor response was assessed with isometric tension measurements. 
Aortic stiffness was measured in vivo by Doppler ultrasound and assessed using 
pulse wave velocity estimation. Collagen deposition was analyzed in the vascular 
adventitia and media with Masson’s trichrome stain.  
 Results. PVAT specific adiponectin expression was decreased in 
Fabp4cre(+).VEGFflox/flox female mice. Our isometric tension measurements 
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revealed a dose-dependent dysfunction in response to acetylcholine within the 
distal aortic segment of Fabp4cre(+).VEGFflox/flox female mice. Aortic stiffness 
estimation via pulse wave velocity revealed no difference in VEGF-A deficient 
mice. Fabp4cre(+).VEGFflox/flox male mice exhibited increased aortic deposition of 
collagen within the thoracic adventitial and medial spaces.  
 Conclusion. These data demonstrate that decreased expression of VEGF-
A within the surrounding adipose tissue microenvironment of thoracic aorta has a 
potentially detrimental effect on vascular function and structure. Modulation of 
angiogenic pathways within PVAT may offer an important avenue towards the 
treatment of adipose tissue dysfunction and prevention of related metabolic 
disorders and cardiovascular diseases.  
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INTRODUCTION 
  
The prevalence of obesity has steadily become a major worldwide health 
concern that has nearly doubled since 1980 (“WHO | Obesity and overweight”). A 
2012 report by Finkelstein et al., suggests that by 2030, ~42% of the United 
States population will be classified as obese. According to the Centers for 
Disease Control and Prevention, obesity increases the risk of developing type 2 
diabetes, hypertension, and a variety of cardiovascular diseases that include 
coronary artery disease, stroke, and myocardial infarction. Obesity is also 
frequently associated with metabolic abnormalities such as dyslipidemia and 
impaired glucose tolerance.  
 
Perivascular and Brown Adipose Tissue Characteristics 
Adipose tissue was initially considered to be merely connective tissue that 
also functioned as a depot for fat storage. However, recent molecular studies 
have shown that the adipose tissue microenvironment has a much more active 
role in maintaining metabolic and vascular homeostasis than previously thought 
(Szasz, Bomfim, & Webb, 2013). Much of the established research has focused 
on the white adipose tissue (WAT) microenvironment, while brown adipose tissue 
(BAT) has only recently become an area of intense investigation. 
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 BAT is an important center for thermogenesis, and is supported by its 
dense mitochondrial concentration and highly vascularized environment 
compared to WAT (Cannon & Nedergaard, 2004; Enerbäck, 2010). It was 
believed that BAT was absent in adult humans until recent fluorodeoxyglucose 
positron emission tomography studies showed not only its presence, but also 
activity, in clavicular, suprarenal, and periaortic regions (Nedergaard, Bengtsson, 
& Cannon, 2007). Notwithstanding these findings, we currently have a limited 
understanding of the role of BAT in the adult human.  
PVAT, which is located surrounding major arteries, such as the aorta, was 
initially considered a structural support element. However, recent studies have 
shown that thoracic PVAT has a very similar morphological and biochemical 
profile to interscapular BAT (Fitzgibbons et al., 2011). While the exact function of 
PVAT is still being explored, functional adipokines and cytokines are known to be 
released from PVAT in both humans and mice. Non-invasive imaging studies 
have correlated the amount of PVAT with metabolic syndrome and coronary 
atherosclerosis (Szasz, Bomfim, & Webb, 2013).  
An increasing number of studies suggest that the quality of the adipose 
tissue microenvironment is just as important as the quantity (Sun, Kusminski, & 
Scherer, 2011). Adipose tissue continuously undergoes expansion and 
regression which requires a corresponding growth of the capillary network that 
supplies it, making the angiogenic capacity of adipose tissue among the highest 
in the body (Lemoine, Ledoux, & Larger, 2013). Obesity associated changes with 
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respect to inflammation and hypoxia have been shown to have a direct effect on 
PVAT’s vasomodulating properties (Greenstein et al., 2009).  
PVAT has been shown to release various vasoactive factors such as 
adiponectin, adipocyte-derived relaxing factor, H2O2, leptin, and nitric oxide (NO) 
under physiological conditions. These factors provide an important anti-
contractile response and are necessary for maintaining vascular appropriate 
resistance (Fernandez-Alfonso et al., 2013). We hypothesize that this dysfunction 
could progress due to perturbations in angiogenesis, causing reductions in 
perfusion of adipose tissue and potentially leading to hypoxia.  
 
VEGF-A 
VEGF-A is a major factor responsible for angiogenesis (Ferrara, Gerber, & 
LeCouter, 2003). Adipocyte hyperplasia and hypertrophy are supported by 
increased neovascularization and dilation, respectively (Christiaens & Lijnen, 
2010). Obese mice display capillary rarefaction in their WAT and reduction of 
VEGF-A expression (Sun et al., 2012). VEGF-A (17 – 23kDa) in mice is 
produced preferentially in VEGF-A120, VEGF-A164, VEGF-A188 isoforms and 
acts upon two tyrosine kinase vascular endothelial growth factor receptor-1, 2 via 
a dose dependent process (Ferrara, Gerber, & LeCouter, 2003; Sun et al., 2012).  
The importance of VEGF in adipose tissue has been shown in two studies, 
where VEGF was overexpressed and the negative effects of diet-induced obesity 
were ameliorated (Sun et al., 2012; Elias et al., 2012).    
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 Additionally, a study on adipose-specific VEGF deficient mice has 
demonstrated its importance in maintaining metabolic function such as glucose 
tolerance (Sung et al., 2013). VEGF expression has also recently been shown to 
be necessary for BAT development and proliferation (Bagchi et al., 2013). 
However, these studies did not explore the possible contributions of BAT or 
PVAT specific VEGF expression towards macrovascular dysfunction. 
 
Acetylcholine & Nitric Oxide  
 An important step in the vasodilation of aortic vessels in normal physiology 
is the release of acetylcholine (ACh). This initiates two responses concurrently 
and the net effect represents a competition between the two. ACh acts via an 
endothelium dependent mechanism to increase NO production through 
endothelial nitric oxide synthase (eNOS) as well as an increase in the production 
of thromboxane A2 and prostaglandin H2 through the cyclooxygenase (COX) 
pathway (Traupe et al., 2002).  
Obesity is also linked with higher levels of oxidative stress markers that 
include reactive oxygen species (ROS) and certain COX mediated metabolites of 
arachidonic acid. ROS, particularly superoxide anion, has been shown to be a 
scavenger of NO and is suspected to be one of the pathways that lead to a 
decreased NO bioavailability in obesity (Chinen et al., 2007). It has been shown 
that with obesity there is an infiltration of macrophages in PVAT and a pro-
inflammatory phenotype (Withers et al., 2011). Taken together, it is possible that 
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decreased VEGF-A expression and increased oxidative stress, disrupts the 
balance of normal vasomotor regulations.  
 
Adiponectin 
Adiponectin is one of several important molecules by which PVAT is able 
to maintain vascular homeostasis. Patients with obesity and cardiovascular 
disease have lower plasma and adipose tissue levels of adiponectin (Arita et al., 
1999; Berg & Scherer, 2005). Several studies have shown that decreased PVAT-
derived adiponectin under conditions of diet-induced obesity is linked to 
decreased adipose tissue vascularity, macrophage infiltration, and neointimal 
thickening (Takaoka et al., 2009; Greenstein et al., 2009; Eringa, Bakker, & van 
Hinsbergh, 2012). We predict that our Fabp4cre(+)VEGFflox/flox model will produce 
decreased PVAT adiponectin expression due to capillary rarefaction and a 
dysfunctional adipose tissue state as present in obesity. 
 
Arterial Stiffness 
One of the hallmarks of obesity induced cardiovascular disease is arterial 
stiffening which has been shown to precede systolic hypertension, stroke and 
heart disease (Weisbrod et al., 2013). Arterial stiffness can be classified based 
on a number of different indices which include pulse wave velocity (PWV), 
compliance, elasticity, and distensibility (Mackenzie, Wilkinson, & Cockcroft, 
2002).  
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Vessel wall compliance is based on several different factors of which the 
scaffolding proteins, collagen and elastin, play a major role. Normally these two 
structural elements are kept in a closely regulated balance, however when the 
vessel wall is exposed to an inflammatory state, such as in obesity, catabolic 
metalloproteases produced from infiltrating inflammatory cells degrade the 
extracellular matrix. The resulting change leads to an overproduction of collagen 
and destruction of elastin (Shirwany & Zou, 2010). This arterial stiffening 
increases the hemodynamic forces transmitted to peripheral vessels and leads to 
impairment in the microcirculation of highly perfused tissues.  
Most of the current data regarding adipose-tissue induced vascular 
dysfunction is based on transplantation of visceral WAT to target vessels 
(Ohman et al., 2011), (Takaoka et al., 2009). Yet, WAT is phenotypically and 
metabolically distinct from thoracic PVAT, while the latter being more similar to 
BAT. As such, the prior studies on thoracic PVAT do not provide an accurate 
assessment of PVAT’s role in vascular function.  
Our study was designed to investigate the role of VEGF-A in thoracic 
PVAT and macrovascular function in mice aorta. We hypothesize that impaired 
angiogenesis in PVAT, as present in obesity, will negatively affect vasomotor 
function and increase arterial stiffness 
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METHODS 
Animals 
 For this study, we generated mice with adipose-specific VEGF-A ablation 
by crossing fatty acid binding protein-4(Fabp4)-cre transgenic mice (#005069, 
Jackson Labs) and VEGFflox/flox mice (provided by Genentech) both on C57BL/6 
genetic backgrounds to create mice that are cre (±) and homozygous for flox 
(Fig. 1A). Fabp4 is a cytoplasmic protein that is highly expressed in adipose 
tissue, macrophages, and has been linked with lipid metabolism (Queipo-Ortuno 
et al., 2012). Characterization demonstrated at least a 50% reduction in VEGF-A 
protein levels in whole white and brown adipose tissue compared to mice 
harboring the cre (-) transgene (Fig. 1B). The VEGF-A levels in the heart and 
lungs did not change regardless of the cre expression (Fig. 1B), which confirms 
the specificity of our VEGF-A ablation. The mice were fed ad libitum on chow diet 
(Tekland Global 18% protein) for the duration of the study.  
Fabp4cre(-).VEGFflox/flox and Fabp4cre(+).VEGFflox/flox mice were 
euthanized by CO2. Visceral WAT was collected and weighed. A portion of the 
WAT was snap frozen in liquid nitrogen for RNA analysis and another portion 
was fixed in 10% neutral buffered formalin (NBF) for future histological analysis. 
Interscapular BAT was also collected and cleaned of attached WAT, then 
processed as described above. The Institutional Animal Care and Use 
Committee of Boston University School of Medicine approved these experiments. 
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Figure 1: Generation and characterization of mouse model. A) Our 
mouse model was generated from crossing Fabp4cre(+) mice with VEGFflox/flox 
mice for several generations to produce the experimental mice. B) VEGF 
expression was quantified by ELISA in heart, white adipose (WAT) and brown 
adipose (BAT). *P < 0.01 **P < 0.001 
 
Real-Time Quantitative PCR 
 RNA samples were transcribed to cDNA using a Qiagen QuantiTect® 
reverse transcription kit and a BioRad T100™Thermal Cycler according to 
manufacturer’s instructions. Gene expression in PVAT from Fabp4cre(-
).VEGFflox/flox and Fabp4cre(+).VEGFflox/flox mice was analyzed with ViiA™ 7 Real-
Time PCR system. The reference gene chosen for all samples was 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Taqman expression 
assays were used to analyze expression of adiponectin and uncoupling protein-1 
(UCP-1). Relative mRNA quantitation was calculated by the ∆∆Ct method, and 
expressed as fold change relative to Fabp4cre(-).VEGFflox/flox mice. 
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Isometric Tension Measurement 
 The thoracic aorta was collected with the heart attached and placed in a 
chilled physiological salt solution (PSS) (KCl 4.7mM, CaCl2 2.5mM, KH2PO4 
1.2mM, MgSO4 0.6mM, NaHCO3 25mM, NaCl 118.3mM, dextrose 5.5mM). The 
PVAT was carefully removed using a dissecting microscope and snap frozen in 
liquid nitrogen for RNA analysis. The heart was removed, weighed, and fixed in 
10% NBF. Each aorta was subsequently cut into 3, 4mm long sections starting 
1mm distal to the left subclavian artery branch from the aortic arch as indicated in 
(Fig. 2). 
 
Figure 2: Schematic diagram of analyzed rings for isometric tension 
measurements.   
 
All samples had intact endothelium and were mounted on 0.005" diameter 
stainless steel stirrups in organ chambers while connected to a horizontal 
myograph force transducer (model TRN001, Kent Scientific Co.). Recording was 
done with a Grass Instruments model 7D Polygraph with a chart speed set to 
5mm/min. The aortic rings were kept at 37ºC and bubbled continuously with a 
95% O2 / 5% CO2 air mixture. The rings were incrementally stretched with 
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repeated washings to an optimal tension of 2g within 1-hour and allowed to 
equilibrate for 30-min. The rings were then contracted with a 50mM KCl PSS for 
15-min and then repeatedly rinsed with standard PSS and allowed 30-min to 
equilibrate.  
Each ring was then contracted with cumulative doses of phenylephrine to 
60 – 70% of their respective 50mM KCl max. Once a stable contraction was 
reached, the rings were challenged via cumulative half log increments of ACh, 
starting from 10-8 M to a final concentration of 10-5 M. After repeated washings 
with standard PSS and another 30-min equilibration, the rings were once again 
contracted to 60 – 70% of their 50mM KCl max and then challenged via 
cumulative half log increments of sodium nitroprusside (SNP) starting from 10-10 
M to a final concentration of 10-5 M.  Relaxation was expressed as a percent 
decrease from their respective phenylephrine induced contractions.  
 
Pulse Wave Velocity Measurements   
Before starting PWV measurements, the mouse was briefly anesthetized 
with a 2% isoflurane/air mixture then quickly placed in a recumbent position on a 
heated platform. Each paw was secured with tape and electrical contact gel to 
their respective electrocardiograph (ECG) pads to measure the heart rate. 
Anesthetic delivery – via a nose cone – was adjusted to 0.5-1% isoflurane/air 
mixture to maintain a target heart rate of 400-500bpm during the procedure. 
Abdominal hair was gently removed using a depilatory cream. Imaging was 
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performed using a Visual Sonics VEVO770 ultrasound imaging system with a 
high-resolution 40MHz scan-head.  
While in B-mode and pulse repetition frequency set to 40 kHz, the scan-
head was placed over the abdomen at the level of the kidney and the renal vein 
was identified as an anatomical landmark. The aorta was verified through Pulse 
Wave Doppler (PWD) and M-mode verification at which point the scan-head was 
rotated 90º counter-clockwise to visualize the aorta longitudinally. Proximal and 
distal points relative to the heart were chosen and aortic flow waveforms were 
collected in PWD mode.  
To obtain the arrival time of the aortic pulse wave, the distance between 
the peak of the ECG R-wave and the foot of the Doppler waveform was 
measured for proximal and distal location using the VEVO770 software. 
Measurements were calculated over 7 cardiac cycles per location, the highest 
and lowest arrival times were discarded and the remaining 5 cycles were 
averaged. The PWV (mm/ms) was calculated by subtracting the average distal 
and proximal arrival times then dividing by the distance between each point to 
obtain the transit time.  
 
Histological Characterization of Aorta 
The aortas were flushed with phosphate buffered saline and then gently 
perfused with 10% NBF to maintain a patent lumen. The aortas were removed 
with PVAT attached and fully fixed in 10% NBF overnight then prepared for 
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embedding in paraffin wax. 5µm specimens were cut and stained using a 
Masson trichrome kit (Sigma-Aldrich HT15-KT). The level of collagen deposition, 
indicated by an Aniline blue stain, was analyzed using Photoshop CS6 as a 
percentage of the aortic wall to normalize variations in aortic size. 
 
Statistical Analysis 
 These data are presented as means ± SEM and a Student’s two tailed t-
test was used for comparison between groups. A P-value < 0.05 is considered 
statistically significant.   
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RESULTS 
 
Effect of Adipose Specific VEGF Deficiency on Organ Weight 
 
 To determine the systemic effects of our murine model, various organs 
from both male and female Fabp4cre(+).VEGFflox/flox mice were weighed and 
compared to their respective Fabp4cre(-).VEGFflox/flox controls at 25 – 29 weeks 
of age (Fig. 3A-B). Male [cre (+) 45.6 ± 6.8 mg vs. cre (-) 81.6 ± 12.5 mg] and 
female [cre (+) 41.9 ± 3.3 mg vs. cre (-) 59.5 ± 4.5 mg] mice maintained on a 
chow diet displayed a significant decrease in interscapular BAT weight. This is 
likely due to BAT being much more vascularized and metabolically active 
compared to WAT and thus more sensitive to VEGF-A ablation. The visceral 
WAT in both male and female [cre (+) 611.7 ± 85.6mg vs. cre (-) 345.3 ± 81.3mg, 
P-value = 0.0858] mice increased but was not statistically significant. 
Hypertension and cardiomegaly are associated with increased arterial stiffness, 
yet our observations did not show a significant difference in cardiac size in both 
male [cre (+) 162.2 ± 9.9mg vs. cre (-) 192.0 ± 24mg] and female [cre (+) 130.0 ± 
9.2mg vs. cre (-) 137.0 ± 6.4mg] groups.  
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Figure 3: Average organ weights of Fabp4cre(±).VEGFflox/flox mice. 
Average weight of heart, kidney (Ki), BAT, white adipose tissue (WAT), and 
spleen (SPLN) from cre (±) male and female mice. A) Female cre (+) (n=6-11) 
and cre (-) (n=4). B) Male cre (+) (n=4) and cre (-) mice (n=5).      *P < 0.05 
 
 
Real-Time Quantitative PCR on PVAT 
Since adiponectin is known to be expressed by PVAT, we sought to 
determine if VEGF ablation would affect the levels of adiponectin expressed in 
PVAT of our Fabp4cre(+).VEGFflox/flox mice. We observed a significant decrease 
in adiponectin expression in female Fabp4cre(+).VEGFflox/flox PVAT compared to 
the Fabp4cre(-).VEGFflox/flox group (Fig. 4). These data suggest that VEGF-A can 
potentially influence vascular function through decreased adiponectin expression. 
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Figure 4: PVAT gene expression. RT-PCAR analysis of PVAT from 
female Fabp4cre(+).VEGFflox/flox mice (n=9)  is reported as fold-change relative to        
Fapb4cre(-).VEGFflox/flox (n=3) control mice, normalized to GAPDH.  *P < 0.05 
 
 
Relaxation Response in Thoracic Aorta  
 
 We hypothesized that the decreased adipose tissue vascularity will lead to 
impaired vasomotor response to pharmacological challenges, which is a 
prognostic indicator of vascular dysfunction. We did not observe a change in ACh 
dependent relaxation responses between female Fabp4cre(±).VEGFflox/flox 
proximal rings (Fig. 5A). The Fabp4cre(+).VEGFflox/flox middle rings began to 
experience an impaired relaxation response compared to Fabp4cre(-).VEGFflox/flox 
mice at elevated ACh concentrations, although this was not significant (Fig. 5B). 
In contrast, we observed a significant decrease to ACh dependent relaxation in 
the distal rings of female Fabp4cre(+).VEGFflox/flox mice which became impaired 
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at a concentration of [3x10-6 mol/L] (Fig. 5C). This dysfunction can be observed 
in the original recording upon the addition of ACh (Fig. 5D). These results 
suggest that there is potentially a localized impairment to endothelium dependent 
ACh relaxation of thoracic aorta, in the absence of VEGF from the surrounding 
adipose tissue. We did not observe impaired ACh-induced relaxation responses 
in our male Fabp4cre(+).VEGFflox/flox mice (Fig. 6A-D). Increasing our future 
sample size will likely clarify our observations and help determine if there is a 
gender-specific difference in our model. 
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Figure 5: Female Fabp4cre(+).VEGFflox/flox mice ACh-induced 
relaxation response is impaired in thoracic aorta. ACh response is expressed 
as % relaxation of a PE induced contraction. A) Proximal ring relaxation 
response cre (+) (n=6) and cre (-) (n=4). B) Middle ring relaxation response cre 
(+) (n=9) and cre (-) (n=4). C) Distal ring relaxation response cre (+) (n=9) and 
cre (-) (n=4) D) Representative micrograph of distal ring recordings.  *P < 0.05 
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Figure 6: Male Fabp4cre(+).VEGFflox/flox mice ACh-induced relaxation 
response is unimpaired in thoracic aorta. ACh response is expressed as % 
relaxation of a PE induced contraction. Fabp4cre(+).VEGFflox/flox (n=3) and 
Fabp4cre(-).VEGFflox/flox (n=3) for all rings. A) Proximal ring relaxation response. 
B) Middle ring relaxation response. C) Distal ring relaxation response D) 
Representative micrograph of distal ring recordings. 
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SNP is an endothelium-independent NO donor with direct relaxing action 
on vascular smooth muscle. As a result, SNP measures indicate if any impaired 
ACh induced relaxation is a result of the smooth muscle’s inability to relax or the 
endothelium’s inability to initiate a relaxation response.  
We observed no significant difference in SNP dependent relaxation 
response between both female Fabp4cre(±).VEGFflox/flox proximal (Fig. 7A) and 
distal (Fig. 7B) rings, which indicates that the smooth muscle in our experimental 
rings were responsive to exogenous NO induced relaxation and any ACh 
dependent impairment is likely due to endothelial dysfunction. However, the 
Fabp4cre(+).VEGFflox/flox middle ring displayed a more sensitive initial relaxation 
at an SNP concentration of [1x10-10 mol/L] (Fig. 7B), which is likely due to 
instrument artifacts and not a result of smooth muscle response. Male 
Fabp4cre(±).VEGFflox/flox displayed a similar response to SNP as our female 
groups and confirmed that smooth muscle response to NO was still intact (Fig. 
8A-D). 
 
 
 20 
 
 
Figure 7: Female Fabp4cre(±).VEGFflox/flox mice SNP-induced 
relaxation response is unimpaired in thoracic aorta. SNP response is 
expressed as % relaxation of a PE induced contraction. Fabp4cre(+).VEGFflox/flox 
(n=5) and Fabp4cre(-).VEGFflox/flox (n=4) for all rings. A) Proximal ring relaxation 
response. B) Middle ring relaxation response. C) Distal ring relaxation response. 
D) Representative micrograph of distal ring recordings. *P < 0.05 
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Figure 8: Male Fabp4cre(+).VEGFflox/flox mice SNP-induced relaxation 
response is unimpaired in thoracic aorta. ACh response is expressed as % 
relaxation of a PE induced contraction. Fabp4cre(+).VEGFflox/flox (n=3) and 
Fabp4cre(-).VEGFflox/flox (n=3) for all rings. A) Proximal ring relaxation response. 
B) Middle ring relaxation response. C) Distal ring relaxation response D) 
Representative micrograph of distal ring recordings. 
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Pulse Wave Velocity 
Based on our findings demonstrating impaired relaxation response (Fig. 
5C), we hypothesized that the VEGF deficiency in adipose tissue would lead to 
increased arterial stiffness. In vivo PWV measurements via Doppler ultrasound 
provides an index of arterial stiffness (Wilkinson, Cockcroft, & Webb, 1998). PWV 
estimation is based on the difference in arrival times of systolic pressure waves 
at two locations along the aorta, one proximal and one distal, with a known 
distance apart (Fig. 9A-D). This transit-time method has commonly been used in 
clinical settings and is well described in rats and mice, (Mitchell, Pfeffer, Finn, & 
Pfeffer, 1997; Hartley, Taffet, Michael, Pham, & Entman, 1997; Williams et al., 
2007).  
Fabp4cre(±).VEGFflox/flox mid-age male and female mice were used to 
determine if there was increase in arterial stiffness. Measurements of PWV in 
male [cre(+) 2.75 ± 0.24mm/ms vs. cre(-) 3.14 ± 0.46mm/ms] and female [cre(+) 
2.65 ± 0.30mm/ms vs. cre(-) 2.68 ± 0.28mm/ms] did not change regardless of 
VEGF expression (Fig. 10A-B).  
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Figure 9: Analyzed region of abdominal aorta. A-B) Representative 
proximal (upper panel) and distal (lower panel) graphs used for PWV analysis. 
Measurements were performed during maximum exhalation to prevent 
alterations in PWV from respiration induced movement of aorta. C-D) 
Longitudinal view of abdominal aorta. Proximal and distal Doppler measurements 
were obtained at a depth of 5-6mm from the skin and ~7mm apart.  
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 Figure 10: Abdominal aortic pulse wave velocity is unchanged in 
Fabp4cre(+).VEGFflox/flox mice. A-B) Mid-age male (21 – 25 weeks of age) and 
female (23 – 27 weeks of age) mice, Fapb4cre(+).VEGFflox/flox (n=4-8) and 
Fapb4cre(-).VEGFflox/flox (n=2-8), on chow diet. 
 
 
 
Histological Characterization of Aortic Collagen 
To assess any extracellular remodeling in our adipose-specific VEGF 
deficient murine model, thoracic aorta samples were collected from 10-13 week 
old male Fabp4cre(±).VEGFflox/flox mice maintained on chow diet. 
Collagen levels were analyzed in the adventitial and medial spaces of the 
aorta. Collagen deposition was calculated by first determining the number pixels 
that constituted the vascular media and immediate adventitia then subtracting the 
number of Aniline blue stained collagen pixels using the color range feature in 
Photoshop CS6 (Fig. 11A). There was a significant increase in the level of 
collagen present within the aortic media and adventitia of male [cre(+) 33.82 ± 
2.15% vs. cre(-) 24.25 ± 2.24%] mice (Fig. 11B).  
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Figure 11: Aortic collagen deposition is increased in adipose-specific 
VEGF-A deficient mice. A) Representative photomicrographs of aorta stained 
with Masson’s Trichrome (left panel) and area analyzed in (right panel) (10x 
mag.). B) Quantification of collagen deposition in male Fabp4cre(+).VEGFflox/flox 
(n=4) and Fabp4cre(-).VEGFflox/flox (n=4) groups. *P < 0.05 
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DISCUSSION & FUTURE DIRECTIONS 
 
 The present study was designed to elucidate the effects of capillary 
rarefaction in adipose tissue and subsequent impact on macrovascular function 
Previously performed confocal microscopy on Fabp4cre(±).VEGFflox/flox  PVAT 
shows a decrease in whole tissue vascularity and increased lipid coalescence 
(Fig. 12A). On gross examination, thoracic PVAT from our VEGF-A ablated 
model had visibly “whitened” compared to our control samples (Fig. 12B). The 
results of this study demonstrate that VEGF-A deficiency in PVAT is a 
contributing factor towards several elements of vascular dysfunction. We found 
that our Fabp4cre(+).VEGFflox/flox model displayed decreased aortic relaxation 
and increased collagen deposition in the adventitial and medial spaces of the 
thoracic aorta in mice 10-13 weeks of age on chow diet, suggesting that there is 
an early response to decreased VEGF-A within the PVAT.  
 
Figure 12: Capillary rarefaction in Fabp4cre(+).VEGFfloxflox PVAT. A) 
Representative confocal micrographs depicting PVAT vascularity (visualized by 
BS1-lectin (FITC) for vasculature and BODIPY (Texas Red) for adipocytes) and 
lipid coalescence (white arrowheads) (50µm stack). D) Visible “whitening” of 
Fabp4cre(+).VEGFflox/flox  thoracic PVAT. 
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Assessing Arterial Stiffness 
Our PWV study did not show the increased arterial stiffness that we had 
predicted. One possible explanation could be the location of our ultrasound 
measurements. Anatomical difficulties in obtaining clear PWV measurements at 
the level of the thoracic aorta limited our study to the abdominal aortic region. 
However, rat aortic studies have shown that PVAT at the level of the abdominal 
cavity is metabolically and phenotypically more similar to WAT (Padilla, Jenkins, 
Vieira-Potter, & Laughlin, 2013). Thus, this difference in localized PVAT 
characteristics could be a contributing factor for our observations. If possible, 
performing measurements at the level of the thoracic aorta could provide a more 
precise assessment of the PWV in our murine model. Another possible 
explanation could be the relatively young age of our cohorts.  
A different metric such as the augmentation index (AIx) may provide a 
better assessment of arterial stiffness at younger ages. The AIx measure is 
expressed as augmentation pressure as a percent of pulse pressure. The central 
aortic pressure wave is composed of a forward left ventricle ejection and reverse 
periphery reflected traveling waves. With increased arterial stiffness, the 
transmission velocity of both waves increase, as such, the reflected wave arrives 
earlier in the central aorta and augments the pressure in late systole (Chirinos et 
al., 2005). A human study by McEniery et al., (2005), showed that changes in the 
central AIx was more prominent in younger individuals (< 50 years), whereas 
changes in aortic PWV was more prominent in older individuals (>50 years). This 
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could be measured using an invasive pressure catheter placed at the level of the 
thoracic aorta and could potentially be performed on our mouse model in future 
studies.  
 
VEGF’s role in ROS and NO Production 
Endothelial cells are a dynamic paracrine organ and play a crucial role in 
maintaining vascular tone and mediating inflammatory processes. Endothelial 
dysfunction from obesity-induced metabolic syndrome is characterized by a 
decrease in NO production (Calles-Escandon & Cipolla, 2013). Our isometric 
tension measurements revealed that Fabp4cre(+).VEGFflox/flox distal aortic rings 
exhibited a dysfunctional vasomotor response which suggest that VEGF-A 
deficiency not only has a structural influence but a biochemical one as well. It has 
been shown that spontaneously hypertensive rats exhibit an endothelium-
dependent contractile response to acetylcholine that is associated with a 
decrease in NO bioavailability and increase in ROS (Vanhoutte & Tang, 2008). It 
is possible that the impaired relaxation effect observed in the 
Fabp4cre(+).VEGFflox/flox mice is due to decreased NO signaling.  
The ROS classification encompasses various metabolites, of which 
superoxide anions play a predominate role. Superoxide anions are rapidly 
converted by superoxide dismutases (SODs) to H2O2 which is a stable form ROS 
(N. Ardanaz et al., 2006). There are three SOD isoforms, manganese SOD, 
copper zinc SOD, and an extracellular form of Cu/Zn-SOD, which have been 
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detected in mesenteric PVAT of mice (Gil-Ortega M et al., 2009). H2O2 has been 
shown to have a vasoactive property which produces contractile and anti-
contractile responses on blood vessels via different mechanisms depending on 
the vessels type and its concentration (N. Ardanaz et al., 2006). H2O2 mediated 
contractile properties are due to direct COX activation and a subsequent 
increase of intracellular Ca2+ (T. Suvorava et al., 2005). It has been suggested 
that extracellular H2O2, which is highly permeable to cell membranes, can enter 
vascular smooth muscle cells and stimulate NADPH oxidase-1, a superoxide 
generating enzyme, production (Gao et al., 2006; Ghouleh et al., 2013).   
H2O2 also produces an endothelium-dependent anti-contractile response 
as a result of increased NO release. This increased NO production is secondary 
to an endothelial dependent K+-channel activation and ensuing smooth muscle 
hyperpolarization (Gil-Longo & González-Vázquez, 2005). H2O2 also possesses 
an endothelium-independent relaxation function on vascular smooth muscle. This 
function is dependent on two distinct H2O2 mechanisms; (i) an opening of smooth 
muscle K+ channels by, and (ii) direct activation of smooth muscle soluble 
guanylate cyclase.  
While superoxide anions promotes vessel contraction, H2O2 in-turn can 
also induce its relaxation, as a result the ultimate macrofunctional outcome will 
depend on the balance of their relative PVAT associated production (Gil-Ortega 
M et al., 2009). Therefore, determining the activity of SODs in thoracic PVAT 
might provide valuable information on the influence of oxidative stress. 
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It has been suggested by Fernandez-Alfonso et al., (2013) that a diet-
associated issue which warrants further research is the role of dietary fatty acid 
composition and its corresponding effects on oxidative stress in PVAT. For 
example, a fructose rich diet has been shown to decrease polyunsaturated fatty 
acids while increasing saturated and monounsaturated fatty acids in PVAT. The 
resulting changes in fatty acid composition are associated with a decrease in 
antioxidant enzymes and alterations in vascular function (Rebolledo et al., 2010). 
Among its various roles, VEGF induces NO production (Kimura & Esumi, 
2003). NO is produced through three different NOS enzymes, neuronal NOS, 
inducible NOS, and endothelial NOS (Fig. 13).  
 
Figure 13: VEGF – NO signaling. VEGF influences NO production 
through several different pathways. Immediate NO production is regulated 
through the CaM-Akt pathway while delayed NO production is mediated through 
the PI3K-Akt pathway or upregulation of eNOS synthesis through PKC activation. 
(Modified from Kimura & Esumi, 2003) 
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Future experiments could include isolation of fresh PVAT from 
Fabp4cre(±).VEGFflox/flox  mice and quantification of mRNA expression or protein 
levels from various points downstream of the proposed VEGF pathway. In 
addition, to better understand if there is a role of NO in our murine model we 
could isolate endothelial and PVAT cell populations from Fabp4cre(±).VEGFflox/flox 
aorta. Anti-phospho-eNOS antibody staining could be performed to determine the 
level of eNOS Ser1177 phosphorylation. NO is produced by various cell types in 
picomolar to nanomolar range. Total NO production at specific ACh 
concentrations in endothelial cell populations can be measured with high-
performance liquid chromatography to determine the level of nitrates and nitrites, 
which are stable cellular oxidation products of nitric oxide, secreted within tissue 
baths (Deng, Long, Yu, & Li, 2009).  
Since COX-pathway metabolites are also produced during ACh 
stimulation, it is important to determine if an overproduction of these metabolites 
are responsible for our observed ACh-induced contraction. This can potentially 
provide valuable insight to the competing contractile and relaxation pathways that 
are initiated by ACh stimulation. Isometric tension studies using a non-selective 
COX inhibitor such as indomethacin, and an eNOS inhibitor such as Nω-Nitro-L-
arginine methyl ester (L-NAME) can help elucidate if a COX product is the cause 
of the contractile response. We would expect that indomethacin treatment will 
abolish a contractile response, while L-NAME would enhance it. Further studies 
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can then be performed to determine which COX product is responsible (Zhou et 
al., 2005).  
Another possible avenue to explore mechanistically is through the 
adiponectin pathway. It has been shown that overexpression of adiponectin 
upregulates VEGF expression and vascularization in obese mice while 
maintaining a metabolically healthy state (Aprahamian, 2013). In addition, 
adiponectin has been shown to have a role in maintaining eNOS activity via PI3-
dependent pathways (Antoniades, Antonopoulos, Tousoulis, & Stefanadis, 2009; 
Cheng et al., 2007). Consequently, its decreased expression in our 
Fabp4cre(+).VEGFflox/flox model may be a contributing element for our observed 
endothelial dysfunction.  
Taken together, the potential approaches discussed thus far would help 
definitively determine whether VEGF-A and adiponectin, acting through the 
eNOS/NO pathway, are responsible for the vascular dysfunction that is present in 
obesity. 
 
Extracellular Arterial Remodeling 
With regard to stiffness, it is primarily determined by components of the 
extracellular matrix, which, along with the elastin-to-collagen ratio, decrease 
toward the peripheral vessels as arterial stiffness increases (Marti et al., 2012). 
Collagen type-I and III have been identified as the primary load-bearing proteins 
that comprise a majority of all collagens within the arterial wall (Díez, 2006). 
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Interestingly, it has been shown that endothelial cells grown in rigid tubes do not 
exhibit the level of eNOS stimulation seen in those grown in distensible tubes. 
These studies suggest that increased extracellular matrix collagen deposition 
may contribute to a vicious cycle of increasing stiffness and decreased eNOS 
stimulation (Shirwany & Zou, 2010).  
Multiple mechanisms may be responsible for the extracellular matrix 
remodeling we have observed in our murine model and taken together, our 
findings indicate that decreased adipose-specific VEGF-A could play a causative 
role in this process.  
Studying the effects of a high-fat high-sucrose (HFHS) diet on our murine 
model will be an important step towards determining the extent of vascular 
impairment due to diet-induced obesity. Previous phenotypic characterizations 
from our lab using a long-term (62week) HFHS diet has shown a statistically 
significant difference in the weights of major organ groups from 
Fabp4cre(±)VEGFflox/flox mice (Fig.14). It is possible that we would observe 
changes to arterial stiffness in adipose-specific VEGF deficient mice under 
conditions of HFHS diet stress. 
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Figure 14: Effects of long-term diet-induced obesity on average 
organ weights of Fabp4cre(+).VEGFflox/flox. Average weight of white adipose 
tissue (WAT), brown adipose (BAT), spleen (SPLN), and lymph node (LN) from 
male cre (+) (n=3) and cre (-) (n=4) mice at 69 weeks of age and 62 weeks of 
HFHS-diet. *P < 0.05 
 
 Obesity is a complex pathology that has multiple interacting and 
confounding variables such as hormonal signaling patterns, adipokine receptor 
defects, and numerous behavioral disorders. Under normal to moderate weights, 
PVAT has been shown to upregulate many of its normal cardio-protective factors. 
With increased weight gain, these protective factors have been shown to 
decrease. A state of low-grade inflammation combined with decreased cardio-
protective factors precipitates the vascular dysfunctions in obesity (Fig.15) 
(Fernandez-Alfonso et al., 2013).  
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Figure 15. Proposed schematic of obesity-associated vascular 
dysfunction.  
 
A murine study by Sung et al., (2013), found that mice which had already 
developed adipose specific metabolic dysfunction from a HFHS diet showed 
improved adipose blood perfusion, reduced hypoxia, decreased adipocyte size, 
and improved adipose function after VEGF induction treatments. However, they 
did not explore the role of BAT or PVAT specifically. These findings support the 
notion that adipose dysfunction due to obesity can potentially be a reversible 
phenomenon. Determining if these benefits extend to vascular structure and 
function can provide valuable translational therapy for individuals with obesity-
associated cardiovascular complications.  
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Based on the results of our study, we show that VEGF deficiency has an 
effect on vascular structure and function. Therapeutic targets that modulate the 
VEGF pathway can potentially be beneficial for decreasing adipose and vascular 
complications due to obesity. 
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